Merck Exec Says Growth Will Be Partially Offset By More Than $2B Of Headwinds From Generic Competition And LOE; It Now Expects To Raise Forecast Of $70B In Revenue Mid-2030s From New Growth Drivers
https://onlinexperiences.com/scripts/Server.nxp
Share
Why It Matters
Merck expects to grow bigger in the mid-2030s. But cheaper copies of some drugs will hold back some of that growth.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.